Alnylam Pharmaceuticals
ALNY
#429
Rank
C$75.07 B
Marketcap
C$568.26
Share price
2.02%
Change (1 day)
58.03%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company